Keyphrases
Epstein-Barr Virus
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
B-cell Lymphoma
50%
World Health Organization
50%
Disease Progression
25%
Tumor Cells
25%
Burkitt Lymphoma
25%
Epstein-Barr Virus Infections
25%
Treatment Outcome
25%
Therapeutic Potential
25%
Germinal Center
25%
Lymphoma
25%
Malignancy
25%
New Therapeutics
25%
Carcinogen
25%
Treatment Strategy
25%
Genetic Background
25%
Stratified Treatment
25%
Post-transplant Lymphoproliferative Disorder
25%
Normal B Cells
25%
Lymphomagenesis
25%
Hodgkin Lymphoma
25%
Reclassification
25%
Infection Model
25%
Viral Oncogenesis
25%
Tumor Microenvironment
25%
Patient Stratification
25%
Fifth Edition
25%
Medicine and Dentistry
Epstein Barr Virus
100%
Diffuse Large B-Cell Lymphoma
100%
B-Cell Lymphoma
50%
Infection
25%
B Cell
25%
Hodgkin's Lymphoma
25%
Tumor Cell
25%
Germinal Center
25%
Disease Exacerbation
25%
Epstein-Barr Virus Infection
25%
Carcinogen
25%
Cancer
25%
Carcinogenesis
25%
Burkitt's Lymphoma
25%
Posttransplant Lymphoproliferative Disease
25%
Tumor Microenvironment
25%
Genetic Background
25%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Diffuse Large B Cell Lymphoma
100%
B Cell Lymphoma
50%
Infection
25%
Neoplasm
25%
Burkitt's Lymphoma
25%
Disease Exacerbation
25%
Hodgkin Disease
25%
Carcinogen
25%
Carcinogenesis
25%
Epstein Barr Virus Infection
25%
Posttransplant Lymphoproliferative Disease
25%
Tumor Microenvironment
25%
Immunology and Microbiology
Epstein Barr Virus
100%
B Cell
100%
Tumor Cell
16%
Germinal Center
16%
Viral Disease
16%
Genetic Background
16%
Lymphoproliferative Disorders
16%